Copanlisib (trade name Aliqopa), is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies...Wikipedia

 

Manufacturer's Website: Aliqopa                                                                                                                 Average retail cost: *

 

*This drug is administered by your healthcare practitioner, which usually means it may be expensive.